We are live on ! Find out more
NCM

Narwhal Capital Management Portfolio holdings

AUM $1.45B
1-Year Est. Return 28.39%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+28.39%
3 Year Est. Return
+93.85%
5 Year Est. Return
+119.75%
10 Year Est. Return
+391.36%
AUM
$435M
AUM Growth
+$31.6M
Cap. Flow
+$12.6M
Cap. Flow %
2.89%
Top 10 Hldgs %
28.37%
Holding
157
New
10
Increased
69
Reduced
42
Closed
10

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.63M
2
ABT icon
Abbott
ABT
+$2.55M
3
JCI icon
Johnson Controls International
JCI
+$1.93M
4
AAPL icon
Apple
AAPL
+$1.7M
5
PG icon
Procter & Gamble
PG
+$1.49M

Top Sells

Rank Stock Value
1
VMC icon
Vulcan Materials
VMC
+$9.94M
2
CVS icon
CVS Health
CVS
+$1.86M
3
HCA icon
HCA Healthcare
HCA
+$1.76M
4
DIS icon
Walt Disney
DIS
+$1.69M
5
CELG
Celgene Corp
CELG
+$1.29M

Sector Composition

Rank Sector Weight
1 Technology 14.1%
2 Financials 12.7%
3 Healthcare 10.25%
4 Industrials 9.4%
5 Communication Services 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$190B
$5.03M 1.16%
41,965
+7,615
+22% +$870K
NVS icon
27
Novartis
NVS
$297B
$4.88M 1.12%
64,795
+5,468
+9% +$413K
GS icon
28
Goldman Sachs
GS
$303B
$4.82M 1.11%
18,930
+905
+5% +$222K
ELV icon
29
Elevance Health
ELV
$85.5B
$4.68M 1.08%
20,810
-2,500
-11% -$532K
UL icon
30
Unilever
UL
$136B
$4.62M 1.06%
74,253
+1,600
+2% +$101K
GLD icon
31
SPDR Gold Trust
GLD
$141B
$4.58M 1.05%
37,050
+1,150
+3% +$139K
BX icon
32
Blackstone
BX
$110B
$4.34M 1%
135,455
+31,700
+31% +$1.03M
OA
33
DELISTED
Orbital ATK, Inc.
OA
$4.26M 0.98%
32,430
-3,510
-10% -$466K
LMT icon
34
Lockheed Martin
LMT
$136B
$4.24M 0.97%
13,205
+175
+1% +$55.2K
ORCL icon
35
Oracle
ORCL
$423B
$4.2M 0.97%
88,850
+27,910
+46% +$1.37M
BUD icon
36
AB InBev
BUD
$165B
$4.19M 0.96%
37,585
+1,645
+5% +$194K
GE icon
37
GE Aerospace
GE
$384B
$4.1M 0.94%
48,996
+897
+2% +$85.6K
AXP icon
38
American Express
AXP
$230B
$3.89M 0.89%
39,125
+1,425
+4% +$136K
SWKS icon
39
Skyworks Solutions
SWKS
$10.6B
$3.65M 0.84%
38,468
+9,873
+35% +$1.03M
RTX icon
40
RTX Corp
RTX
$301B
$3.63M 0.84%
45,247
+795
+2% +$60.4K
CCMP
41
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$3.61M 0.83%
38,335
+1,550
+4% +$143K
EPD icon
42
Enterprise Products Partners
EPD
$81.7B
$3.57M 0.82%
134,505
+28,180
+27% +$714K
PM icon
43
Philip Morris
PM
$295B
$3.55M 0.82%
33,640
-2,800
-8% -$298K
JCI icon
44
Johnson Controls International
JCI
$92.2B
$3.34M 0.77%
87,598
+49,398
+129% +$1.93M
VLO icon
45
Valero Energy
VLO
$85.9B
$3.28M 0.75%
35,725
-300
-0.8% -$24.8K
AMGN icon
46
Amgen
AMGN
$222B
$3.26M 0.75%
18,760
+250
+1% +$44.2K
CVX icon
47
Chevron
CVX
$366B
$3.26M 0.75%
26,050
QCOM icon
48
Qualcomm
QCOM
$176B
$3.25M 0.75%
50,835
-4,775
-9% -$290K
MRK icon
49
Merck
MRK
$318B
$3.04M 0.7%
56,546
+24,362
+76% +$1.35M
GILD icon
50
Gilead Sciences
GILD
$165B
$3.03M 0.7%
42,310
+2,980
+8% +$226K

Similar funds

Narwhal Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Narwhal Capital Management held 157 positions worth $435M, up 7.8% from $403M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Narwhal Capital Management's Q4 2017 filing shows 10 new, 69 increased, 42 reduced and 10 closed positions. Its largest new stake was Abbott: 45,967 shares worth $2.62M. The largest sale was Vulcan Materials, an estimated $9.94M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Narwhal Capital Management's largest Q4 2017 buy was Abbott: 45,967 shares worth $2.62M.
  • Narwhal Capital Management added most to UnitedHealth in Q4 2017, an estimated $2.63M increase.
  • Narwhal Capital Management's biggest Q4 2017 reduction was Vulcan Materials, cutting an estimated $9.94M.
  • Narwhal Capital Management fully exited Celgene Corp in Q4 2017, selling an estimated $1.29M.
  • Narwhal Capital Management's ten largest holdings make up 28% of its $435M portfolio in Q4 2017.
  • Narwhal Capital Management opened 10 new positions and closed 10 in Q4 2017.
  • Narwhal Capital Management's portfolio value rose 7.8% quarter-over-quarter to $435M.

Based on Narwhal Capital Management's 13F filing for Q4 2017, filed 23 Jan 2018.